Actively Recruiting

Phase Not Applicable
Age: 18Years +
All Genders
NCT06941155

Gamified Combined Cognitive Bias Modification in Adults Diagnosed With OCD: Randomized Controlled Trial

Led by Dokuz Eylul University · Updated on 2025-05-15

90

Participants Needed

1

Research Sites

98 weeks

Total Duration

On this page

Sponsors

D

Dokuz Eylul University

Lead Sponsor

T

The Scientific and Technological Research Council of Turkey

Collaborating Sponsor

AI-Summary

What this Trial Is About

This randomized controlled trial examines the effects of a mobile-based gamified combined cognitive bias modification (CBM-C) intervention on obsessive-compulsive symptoms, obsessive beliefs, attentional and interpretation biases, depressive symptoms, and psychological distress. The gamified CBM-C condition is compared to a standard mobile-based CBM-C and a placebo control condition. All interventions are delivered via a mobile application. Assessments are conducted at baseline, post-intervention (week 4), and 3-month follow-up.

CONDITIONS

Official Title

Gamified Combined Cognitive Bias Modification in Adults Diagnosed With OCD: Randomized Controlled Trial

Who Can Participate

Age: 18Years +
All Genders

Eligibility Criteria

Eligible

You may qualify if you...

  • Age 18 years or older
  • Primary diagnosis of obsessive-compulsive disorder (OCD) confirmed by a licensed clinician using Structured Clinical Interview for DSM-5 (SCID-5)
  • No current suicidal ideation or psychotic symptoms
  • Access to the internet and a mobile phone
  • Stable psychiatric medication use for at least one month prior to enrollment, with no dosage changes during the 4-week intervention
  • No current neurological or medical condition interfering with participation
  • Ability to perceive colored visual stimuli (no color blindness)
  • Not enrolled in another intervention-based study
  • Not receiving any other psychological treatment during participation
Not Eligible

You will not qualify if you...

  • Presence of active suicidal ideation or psychotic symptoms
  • Unstable psychiatric medication use (recent or expected dosage changes during intervention)
  • Significant neurological or medical illness interfering with participation
  • Visual impairments preventing accurate perception of colored stimuli (e.g., color blindness)
  • Current participation in another clinical trial involving psychological intervention
  • Receiving concurrent psychotherapy or other psychological treatments outside the study

AI-Screening

AI-Powered Screening

Complete this quick 3-step screening to check your eligibility

1
2
3
+1

Trial Site Locations

Total: 1 location

1

Dokuz Eylul University Hospital

Izmir, Turkey (Türkiye), 35340

Actively Recruiting

Loading map...

Research Team

S

Sıla Derin, PhD

CONTACT

O

Orçun Yorulmaz, Prof. Dr.

CONTACT

How is the study designed?

Study Type

INTERVENTIONAL

Masking

SINGLE

Allocation

RANDOMIZED

Model

PARALLEL

Primary Purpose

TREATMENT

Number of Arms

3

Not the Right Trial for You?

Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.

Already have an account? Log in here